ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      6,025.99
      -0.95%
      US Tech 100
      20,874.00
      -1.46%
      Dow Jones
      44,303.40
      -0.99%
      Brent Oil
      74.565
      0.00%
      Bitcoin
      96,461.53
      -0.09%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Sanofi (SAN) Quote

      Sanofi

      Sanofi (SAN)

      Sagalio Energy Ltd
      Sant Uk.10te%
      Banco Santander SA
      103.36
      -0.36
      (-0.35%)
      Closed February 08 11:30AM
      Delayed by 15 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      103.36
      Bid
      102.74
      Ask
      103.70
      Volume
      2,066,340
      100.40 Day's Range 103.70
      84.93 52 Week Range 106.14
      Market Cap
      129.473B
      Previous Close
      103.72
      Open
      100.74
      Last Trade
      150
      @
      103.36
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      1,593,295
      Shares Outstanding
      1,252,640,466
      Dividend Yield
      10.72%
      PE Ratio
      23.98
      Earnings Per Share (EPS)
      4.31
      Revenue
      43.07B
      Net Profit
      5.4B

      About Sanofi

      Sector
      Health & Allied Services,nec
      Industry
      Pharmaceutical Preparations
      Website
      www.sanofi.com
      Headquarters
      Paris, Paris, Fra
      Founded
      1994
      Sanofi is listed in the Health & Allied Services sector of the Euronext with ticker SAN. The last closing price for Sanofi was 103.72 €. Over the last year, Sanofi shares have traded in a share price range of 84.93 € to 106.14 €.

      Sanofi currently has 1,252,640,466 shares outstanding. The market capitalization of Sanofi is 129.92 € billion. Sanofi has a price to earnings ratio (PE ratio) of 23.98.

      Ask ADVFN Intelligence (AI)

      SAN Latest News

      More News

      Press Release: Execution of a share buyback agreement for up to €2 billion

      Press Release: Execution of a share buyback agreement for up to €2 billion Execution of a share buyback agreement for up to €2 billion Paris, February 7, 2025. On January 30, 2025, Sanofi...

      February 07 2025
      UK Regulatory

      Communiqué de presse : Sanofi annonce la signature d’un mandat de rachat d'actions pour un montant maximum de 2 milliards d’euros

      Communiqué de presse : Sanofi annonce la signature d’un mandat de rachat d'actions pour un montant maximum de 2 milliards d’euros Sanofi annonce la signature d’un mandat de rachat d'actions...

      February 07 2025
      UK Regulatory

      Press Release: Execution of a share buyback agreement for up to €2 billion

      Execution of a share buyback agreement for up to €2 billion Paris, February 7, 2025. On January 30, 2025, Sanofi announced its intention to execute a share buyback program in 2025 of €5 billion...

      February 07 2025
      GlobeNewswire Inc.

      Press Release: Sanofi announces buy back of shares from L’Oréal

      Press Release: Sanofi announces buy back of shares from L’Oréal Sanofi announces buy back of shares from L’Oréal Paris, February 3, 2025. Sanofi today announces the acquisition of 2.3% of its...

      February 03 2025
      UK Regulatory

      Communiqué de presse : Sanofi annonce un rachat d'actions à L'Oréal

      Communiqué de presse : Sanofi annonce un rachat d'actions à L'Oréal Sanofi annonce un rachat d'actions à L'Oréal Paris, le 3 février 2025. Sanofi annonce aujourd'hui l'acquisition de...

      February 03 2025
      UK Regulatory

      Press Release: Sanofi announces buy back of shares from L’Oréal

      Sanofi announces buy back of shares from L’Oréal Paris, February 3, 2025. Sanofi today announces the acquisition of 2.3% of its shares from long-standing shareholder L’Oréal. This transaction is...

      February 03 2025
      GlobeNewswire Inc.

      Press Release: Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant

      Sarclisa is the first anti-CD38 treatment approved in China for patients with newly diagnosed multiple myeloma ineligible for transplant  Approval based on positive results from the IMROZ phase 3...

      January 31 2025
      GlobeNewswire Inc.

      Communiqué de presse : Croissance des ventes de 10,3% au T4. Objectif du BNPA des activités de 2024 dépassé. Fort rebond du BNPA des activités attendu en 2025

      Communiqué de presse : Croissance des ventes de 10,3% au T4. Objectif du BNPA des activités de 2024 dépassé. Fort rebond du BNPA des activités attendu en 2025 Sanofi: Croissance des ventes de...

      January 30 2025
      UK Regulatory

      Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025

      Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025 Paris, January 30, 2025 Q4: sales growth of 10.3% at CER1 and business...

      January 30 2025
      GlobeNewswire Inc.

      Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025

      Press Release: Q4 sales growth of 10.3%, 2024 business EPS guidance exceeded, and strong business EPS rebound expected in 2025 Sanofi: Q4 sales growth of 10.3%, 2024 business EPS guidance...

      January 30 2025
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.5-0.481417292509103.86104.8100.41810611103.84275677DE
      47.587.9139695134795.78104.893.061662702100.32105882DE
      1211.8712.974095529691.49104.887.5159329595.06366392DE
      269.9110.604601391193.45106.1487.5150623597.96314861DE
      5215.4917.628314555687.87106.1484.93147879594.05545487DE
      15612.313.507577421591.06106.6676.45172361393.02249418DE
      2608.769.260042283394.6106.6667.65193067089.56053348DE

      SAN - Frequently Asked Questions (FAQ)

      What is the current Sanofi share price?
      The current share price of Sanofi is 103.36 €
      How many Sanofi shares are in issue?
      Sanofi has 1,252,640,466 shares in issue
      What is the market cap of Sanofi?
      The market capitalisation of Sanofi is EUR 129.92B
      What is the 1 year trading range for Sanofi share price?
      Sanofi has traded in the range of 84.93 € to 106.14 € during the past year
      What is the PE ratio of Sanofi?
      The price to earnings ratio of Sanofi is 23.98
      What is the cash to sales ratio of Sanofi?
      The cash to sales ratio of Sanofi is 3.01
      What is the reporting currency for Sanofi?
      Sanofi reports financial results in EUR
      What is the latest annual turnover for Sanofi?
      The latest annual turnover of Sanofi is EUR 43.07B
      What is the latest annual profit for Sanofi?
      The latest annual profit of Sanofi is EUR 5.4B
      What is the registered address of Sanofi?
      The registered address for Sanofi is 46, AVENUE DE LA GRANDE ARMEE, PARIS, PARIS, 75017
      What is the Sanofi website address?
      The website address for Sanofi is www.sanofi.com
      Which industry sector does Sanofi operate in?
      Sanofi operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ALCABCabasse SA
      0.77 €
      (67.39%)
      		93.29k
      ALEXPOne Experience
      0.496 €
      (64.24%)
      		2.54k
      VTRVitura
      5.80 €
      (62.92%)
      		2.37k
      DMSBSDiagnostic Medical Systems
      0.007 €
      (40.00%)
      		15.1k
      ALVERVergnet
      0.0009 €
      (28.57%)
      		23.09M
      ALCYBCybergun
      0.0001 €
      (-50.00%)
      		18.59M
      BAIOdyssey Acquisition SA
      0.1285 €
      (-49.80%)
      		834.05k
      ALALOAcheterLouerFR
      0.0148 €
      (-34.80%)
      		2.31M
      MLWEYWeya
      0.018 €
      (-33.33%)
      		52.31k
      MLCOTCoretech 5
      0.0335 €
      (-33.00%)
      		61k
      ATOAtos SE
      0.0021 €
      (0.00%)
      		1.12B
      ALVERVergnet
      0.0009 €
      (28.57%)
      		23.09M
      ALCYBCybergun
      0.0001 €
      (-50.00%)
      		18.59M
      ALHGLouis Hachette Group
      1.331 €
      (-2.90%)
      		11.49M
      BCPBanco Comercial Portugues SA
      0.5008 €
      (-1.14%)
      		10.67M

      Discussion

      View Full Feed
      ORCA ORCA 4 minutes ago
      THE OTC UPDATED THE SS.NO CHANGE.THE MARKET CAP IS A RIDICULOUS $1,4 MILLION.IT COULD BE AROUND $10 MILLION CAP OR .0093 PPS.A TREMENDOUS ROOM FOR THE STOCK TO RUN BIGLY.
      https://www.otcmarkets.com/stock/BLLB/security
      BLLB Security Details
      Share Structure
      Market Cap Marke
      BLLB
      SC8 SC8 5 minutes ago
      ? You already acknowledged the competitor that already has and has a 2.5 year head start in clinical trials over RDGL. As far larger companies, the profit just isn't there for the big boys to develop a generic public domain product. It would be like expecting a big pharma company to investigate r
      RDGL
      dukeb dukeb 5 minutes ago
      The feeling appears to be mutual...

      https://investorshub.advfn.com/uimage/uploads/2025/2/8/lfxorMusk_loves_Trump.png
      shotaduck shotaduck 5 minutes ago
      I guess the airport will be finished in 2026 andthe ade i guess would be built and running some time around that. Also sounds like henry is developing a self powered charging station that will be sold all over the world. That would be valued at 100s of billions ....https://www.globenewswire.com/news
      PHIL
      royal1 royal1 7 minutes ago
      You and your « group «  are more obsessed about fertilizer than anyone else.
      HMBL
      JimmyRich JimmyRich 8 minutes ago
      And prior to that said it Beplate that was a scam.. anyone that has any opinion or optimism towards this company is a scam with an agenda.. except you!!! Right???? No scam??? No agenda??? Just Captain America looking out for all the investors..: John Q Citizen you are!!!! You’re a gem 💎…
      UEEC
      B402 B402 8 minutes ago
      Sorry, if you want millions and even billions, you have to be accountable for it....

      Start over, make them accountable or else nothing......I think the people who we are trying to help will come out ahead by leaps and bounds.........Sounds like a worthy dem project that's win win for
      ORCA ORCA 10 minutes ago
      IF BUYING SPREE COMES IN BIG VOLUMES,THIS COULD HIT .01 IN A HURRY.DEPENDS ON THE NEWS TOO.THE FLOATALOGY HAS BEEN ABSORBED.ENORMOUS SHORT SELLING HAS HAPPENED IN THE .0008 AND .0011 AREA.
      THESE BOYS ARE PANICKING.AS A BUYING SPREE WILL REALLY CREATE A HUGE SHORT COVER.NO ONE KNOWS WHERE IT I
      BLLB
      Angelmin Angelmin 10 minutes ago
      Send letters to Baron Trump🤪.  Apparently a father-son relationship is much quicker than celebrities.
      FNMA
      JonDoe1 JonDoe1 10 minutes ago
      spitting
      You've got some serious anger issues.

      negativity without proof of anything
      You've been provided proof of many things but choose to ignore it. Proof of dilution. Proof of the SRGE and CRGP connection via "Benny".Proof of them creating fake management. Proof of t
      CRGP
      trader53 trader53 10 minutes ago
      WCVC - Direct Public Offerings in 2025


      https://investorshub.advfn.com/uicon/155361.png?cb=636360310707230000

      WCVC - Will Be The WINNER
      https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175350907

      ____________________________
      WCVC
      ORCA ORCA 12 minutes ago
      100 MILLION WILL BE ON THE BIDS MONDAY.AND FOR THE WHOLE WEEK.AT ONE TIME THIS WEEK AROUND 150 MILLION WAS ON THE BIDS.THUS THE STOCK DID NOT WANT TO DEEP BELOW .0009.THEN BIG HIGH BID MOVED TO .0009s.
      BLLB
      BBANBOB BBANBOB 12 minutes ago
      And the seats are NOT A LAZY BOY RECLINER EITHER AT ALLLL
      xoom xoom 12 minutes ago
      Bban, on a lighter note, you can only ‘guarantee a payment’ to someone IF it’s from your own pocket, as you directly control the cash flow.
      If you are expecting somebody else to make that payment, you cannot ‘guarantee’ it, as you do not actually control the cash flow.
      COOP
      chereb19 chereb19 13 minutes ago
      The FDA love working with Vivos
      RDGL
      WALLnut WALLnut 13 minutes ago
      Nice try, but you’re still twisting the facts. Yes, the company requests meetings, but the FDA grants them when they see value in discussion. The FDA doesn’t waste time on companies that aren’t making progress—if Vivos was just ‘arguing’ without delivering, the FDA would have stopped engaging long a
      RDGL
      B402 B402 14 minutes ago
      It was the ability to sentence question they answered.....
      Shev11 Shev11 15 minutes ago
      Hey guys I just read PRE 14a on there website and looks like there gonna need another extension even after March 14th which is the current termination date. The board believes there will not be sufficient time before June 14 2025 to complete the business combination. They need approvel of atleast 65
      GTCH
      Ayock Ayock 15 minutes ago
      Those who ban books are never the good guys
      https://scontent-lax3-1.xx.fbcdn.net/v/t39.30808-6/475660543_1029525139202409_4190329433910675118_n.jpg?_nc_cat=105&ccb=1-7&_nc_sid=833d8c&_nc_ohc=3LnhfZ-5Tl8Q7kNvgGVSE68&_nc_oc=AdhvplKPkuaW6WRgEiCuu1-59ah6Xyzd6OY9lmFyqo4qUTQNaC5XGTbhnsmk4xHSJ0M3QL
      fuagf fuagf 16 minutes ago
      Your people are endangering people worldwide and diminishing respect for America.
      LakeshoreLeo1953 LakeshoreLeo1953 17 minutes ago
      After 38 days fermenting you would think it would get better.
      Alas, history suggests NOT.
      AVXL
      bbotcs bbotcs 17 minutes ago
      wadegarret: AESI
      The company's debt-to-cash ratio does not impress me. The recent offering is priced at $23, and with the stock at $21 a share, who is going to buy shares at $23? Is the dividend safe if they cannot finance the acquisition from the stock sale? A momentum stock advisor has

      Your Recent History

      EU
      SAN
      Sanofi
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads